Galvus 50mg Tablet
PDF Leaflet Revision Date: 30 September 2016
Clinical Summary
Quick overview from the medicine insert
Indication
Adjunct to diet and exercise for glycaemic control in type 2 diabetes.
Dosage (summary)
50 mg once daily or 50 mg twice daily depending on combination therapy.
Onset of Action / Duration
Onset: 1.75 hours, Duration: 8-9.6 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- Low potential for interactions
- No significant interactions with common antidiabetics
Contraindications
- Hypersensitivity to vildagliptin
- Hepatic impairment
Common side effects
- Dizziness
- Nausea
- Headache
- Hypoglycaemia
Counselling Points
- Avoid driving if dizzy
- Monitor for signs of liver dysfunction
- Diet and exercise are essential
Serious warnings
- Monitor liver function tests
- Not recommended in NYHA Class III heart failure
Important Disclaimer
The Galvus 50mg Tablet professional information leaflet below is the property of Novartis and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
